HIV and Youth: What CDC is Doing

CDC is pursuing a high-impact HIV prevention approach to maximize the effectiveness of HIV prevention interventions and strategies. Funding state, territorial, and local health departments and community-based organizations (CBOs) to develop and implement tailored programs is CDC’s largest investment in HIV prevention. This includes longstanding successful programs and new efforts funded through the Ending the HIV Epidemic initiative. In addition to funding health departments and CBOs, CDC is also strengthening the HIV prevention workforce and developing HIV communication resources for consumers and health care providers.

  • Under the integrated HIV surveillance and prevention cooperative agreement, CDC awards around $400 million per year to health departments for HIV data collection and prevention efforts. This award directs resources to the populations and geographic areas of greatest need, while supporting core HIV surveillance and prevention efforts across the US.
  • In 2019, CDC awarded $12 million to support the development of state and local Ending the HIV Epidemic plans in the nation’s 57 priority areas. To further enhance capacity building efforts, CDC uses HIV prevention resources to fund the National Alliance of State and Territorial AIDS Directors (NASTAD) with $1.5 million per year to support strategic partnerships, community engagement, peer-to-peer technical assistance, and planning efforts.
  • In 2020, CDC awarded $109 million to 32 state and local health departments that represent the 57 jurisdictions across the United States prioritized in the Ending the HIV Epidemic. This award supports the implementation of state and local Ending the HIV Epidemic plans.
  • Under the flagship community-based organization cooperative agreement, CDC awards about $42 million per year to community organizations. This award directs resources to support the delivery of effective HIV prevention strategies to key populations.
  • In 2017, CDC awarded nearly $11 million per year for five years to 30 CBOs to provide HIV testing to young gay and bisexual men of color and transgender youth of color, with the goal of identifying undiagnosed HIV infections and linking those who have HIV to care and prevention services.
  • In 2019, CDC awarded a cooperative agreement to strengthen the capacity and improve the performance of the nation’s HIV prevention workforce. New elements include dedicated providers for web-based and classroom-based national training, and technical assistance tailored within four geographic regions.
  1. CDC. Diagnoses of HIV infection in the United States and dependent areas, 2018 pdf icon[PDF – 7 MB]. HIV Surveillance Report 2020;31.
  2. CDC. Estimated HIV incidence and prevalence in the United States, 2014-2018 pdf icon[PDF – 3 MB]. HIV Surveillance Supplemental Report 2020;25(1).
  3. CDC. HIV infection risk, prevention, and testing behaviors among men who have sex with men—National HIV Behavioral Surveillance, 23 U.S. Cities, 2017 pdf icon[PDF – 1 MB]. HIV Surveillance Special Report 2019; 22.
  4. CDC. HIV infection risk, prevention, and testing behaviors among persons who inject drugs–National HIV Behavioral Surveillance: injection drug use – 23 U.S. Cities, 2018 pdf icon[PDF – 2 MB]. HIV Surveillance Special Report 2020; 24.
  5. CDC. HIV risk behaviors. Accessed March 18, 2021.
  6. CDC. Behavioral and clinical characteristics of persons with diagnosed HIV infection—Medical Monitoring Project, United States, 2018 cycle (June 2018–May 2019) pdf icon[PDF – 905 KB]. HIV Surveillance Special Report 2020;25.
  7. CDC. Selected national HIV prevention and care outcomes pdf icon[PDF – 2 MB][slides].
  8. CDC. Sexually transmitted disease surveillance, 2018. Accessed March 18, 2021.
  9. National youth risk behavior survey (YRBS). Accessed March 18, 2021.
  10. CDC. School health profiles 2018: Characteristics of health programs among secondary schools.
  11. CDC. Results from the school health policies and practices study, 2016.
  12. Kann L, McManus T, Harris W, et al. Youth risk behavior surveillance—United States, 2017. MMWR 2018;67(8):1-114. PubMed abstractexternal icon.
  13. Siegler AJ, Mouhanna F, Giler RM, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol 2018; 28(12):841-9. PubMed abstractexternal icon.

View Page In:pdf icon PDF [2M]